Postoperative Complications (Cardiopulmonary)SAMPONCT07519733
Preoperative Exercise Testing and Perioperative Outcomes
An observational study of Postoperative Complications (Cardiopulmonary), run by Yale University at 1 site in United States.
Trial summary
The goal of this observational study is to learn whether results from a brief exercise test done before surgery can help identify adults who may be more likely to have problems after moderate- to high-risk noncardiac surgery. Read more about this study
- Who is it for?
- Ages 45 years and olderHealthy volunteers can take part
- Conditions the study is for
- Postoperative Complications (Cardiopulmonary)
- What is being tested?
- Recruited participants receive preoperative rapid submaximal cardiopulmonary exercise testing within the current risk assessment framework of the pre-surgical evaluation clinic
- How many people
- 992 participants
- Where
- 1 siteUnited States
- Study dates
- 23 Jul 2025to 30 Jul 2028
- How long will I take part?
- 1 Year
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: The pool of participants for enrollment in this data repository will be patients that have met criteria for preoperative smCPET screening with EITHER a * Modified Duke Activity Status Index9 score of <3 or Duke Activity Status Index < or = 34 * A surgeon's request for preoperative evaluation to assess fitness for surgery * An anesthesiologist request for preoperative evaluation to assess fitness for surgery. * A consulting physician request for preoperative evaluation to assess fitness for surgery. * Or a revised cardiac risk index10 of >2 with moderate to high risk features (coronary artery disease, cardiomyopathy, echocardiography with reduced ejection fraction, myocardial infarction w/in prior 12 months (but >6 weeks from scheduled surgery).
Who may be able to join
- greater than 45 years old
- moderate to high-risk noncardiac surgery
- surgeon, anesthesiologist or other medical provider requested referral for preoperative high risk evaluation, or
- revised cardiac risk index > or = 2, or
- Ambiguous, low or discordant functional capacity by either the Duke Activity status index (DASI <34) or the modified Duke Activity status index (< or =3) or
- Frailty Index >1
Who cannot join
- Age <45
- Absolute contraindication to submaximal cardiopulmonary exercise testing
- Impaired decision making capacity
- Prisoners
- Pregnancy
- Severe peripheral vascular disease
- Functional limitation precluding the performance of submaximal cardipulmonary exercise testing
- Severe active pulmonary disease
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Yale New Haven Hospital, Pre-Surgical Evaluation Clinic
New Haven, Connecticut, 06520
Zyad J Carr, M.D., 203.785.3689, zyad.carr@yale.edu
About this study
Official title: Submaximal Cardiopulmonary Exercise Testing in Adults Presenting for Moderate to High-risk Surgery and Perioperative Outcomes
The goal of this observational study is to learn whether results from a brief exercise test done before surgery can help identify adults who may be more likely to have problems after moderate- to high-risk noncardiac surgery. The study includes adults older than 45 years who are seen in a pre-surgical evaluation clinic and complete submaximal cardiopulmonary exercise testing, or smCPET, as part of their usual clinical care. The main questions it aims to answer are:
Are smCPET measurements linked with early problems after surgery? Are smCPET measurements linked with later problems after surgery, including complications within 30 and 60 days, longer hospital stay, and death? Can smCPET add useful information to standard preoperative risk assessment? Researchers will observe and analyze information collected during routine care. No extra exercise testing or treatment will be done for research.
Read more
Participants will:
- Complete routine preoperative evaluation in the Yale Pre-Surgical Evaluation Clinic.
- Undergo smCPET if it is ordered as part of standard clinical care.
- Allow researchers to collect information from the medical record and from the exercise test for the study repository, if they agree to participate.
The study will collect de-identified information about each participant's health before surgery, exercise test results, details about the surgery and hospital stay, and problems that happen after surgery. This may include age, sex, body mass index, other medical conditions, routine lab and imaging results, heart rate, blood pressure, oxygen levels, smCPET measures such as peak oxygen uptake, anaerobic threshold, and breathing efficiency, and early and late postoperative outcomes.
Researchers will look at short-term and later outcomes after surgery. These include problems identified during the hospital stay, such as heart, lung, kidney, nerve, blood, wound, and pain-related complications, as well as complications within 30 and 60 days after surgery. Researchers will also study hospital length of stay and death after surgery.
This study is designed to help researchers understand whether a short, practical exercise test can improve the way surgical risk is assessed before an operation. Current preoperative assessment tools do not always measure how well the heart, lungs, and muscles work together during physical stress. smCPET may provide a more objective way to measure functional capacity and physiologic reserve in a busy clinic setting.
This is a single-center study based in a preoperative evaluation clinic. The study has a prospective observational cohort component and a retrospective validation component. In the prospective part, adults who meet clinic criteria and complete smCPET during routine care may be asked to join the repository. In the retrospective part, researchers may also review historical data from patients evaluated before smCPET was put into routine use to help compare outcomes and validate findings.
Because this is an observational repository study, participation does not change the care participants receive. The exercise test is done for clinical reasons, not because of the research study. The research team will not assign treatments or decide what surgery a participant has. Instead, the team will study how exercise test findings relate to outcomes that occur after surgery.
The long-term aim of this study is to improve preoperative risk assessment and help clinicians better identify patients who may need closer monitoring, more evaluation, or more support around the time of surgery. If the findings are useful, they may support broader use of brief preoperative exercise testing in adults having higher-risk noncardiac surgery.
Read the detailed description
Submaximal Cardiopulmonary Exercise Testing in Adults Presenting for Moderate- to High-risk Surgery and Perioperative Outcomes (SAMPO) is a single-center prospective observational cohort repository with a retrospective validation component designed to evaluate whether measures derived from brief, clinically integrated submaximal cardiopulmonary exercise testing (smCPET) are associated with perioperative outcomes in adults undergoing moderate- to high-risk noncardiac surgery. The repository is being developed in the Yale New Haven Hospital Pre-Surgical Evaluation Clinic to support systematic collection, curation, and analysis of exercise-derived physiologic data obtained during routine preoperative care, together with clinical, perioperative, and postoperative outcome data. The overall purpose is to determine whether smCPET variables can improve perioperative risk stratification, identify patients at increased risk for postoperative complications, and generate a scalable framework for future perioperative risk modeling and implementation studies.
Perioperative complications remain common after major noncardiac surgery and are associated with increased morbidity, prolonged recovery, higher readmission rates, greater resource use, and higher health care costs. Current preoperative risk assessment often relies on history, comorbidity burden, procedural risk classification, and subjective estimates of functional capacity. Although formal cardiopulmonary exercise testing has demonstrated value for perioperative prognostication, broad adoption has been limited by the time, personnel, technical, and infrastructure requirements of conventional maximal testing. A brief submaximal approach may offer a more pragmatic alternative in the preoperative clinic setting. Early implementation work by the investigators suggests that rapid smCPET can be integrated into routine workflow, produces technically usable data in a high proportion of patients, and may yield physiologic measures associated with early postoperative morbidity. This repository is intended to extend that work by creating a structured dataset that allows more rigorous assessment of the relationship between preoperative smCPET findings and clinically meaningful postoperative outcomes.
The central scientific premise of the repository is that preoperative physiologic response to submaximal exercise reflects cardiopulmonary reserve and integrative functional capacity in ways not fully captured by routine clinical history or conventional screening instruments. Variables such as peak oxygen uptake achieved during submaximal effort, anaerobic threshold, ventilatory efficiency, heart rate response, and slope-based exercise measures may identify latent vulnerability before surgery. If those measures show meaningful associations with early and later postoperative complications, they may support more objective risk assessment, perioperative triage, allocation of optimization resources, and selection of patients for enhanced monitoring or future interventional studies. The repository is therefore designed not merely as a passive data storage effort, but as an analytic infrastructure for validating clinically feasible physiologic markers in the perioperative setting.
The study includes a prospective component and a retrospective component. In the prospective component, adult participants undergoing routine preoperative evaluation in the Yale Pre-Surgical Evaluation Clinic who are referred for or complete smCPET as part of clinical care are approached for consent for inclusion in the repository. smCPET is not performed for research purposes; rather, the study captures data already generated during standard clinical assessment and links those data to perioperative and postoperative outcomes. The planned initial enrollment period is 36 months with follow-up extending through the perioperative period and including later outcome ascertainment. The protocol also describes an overall study duration of 48 months and a single study site.
The retrospective component consists of historical data from the period before clinical implementation of smCPET, including approximately 24 months of historical control data to support validation, comparison, matched cohort analyses, and evaluation of outcomes, costs, and resource utilization patterns. This aspect of the study is intended to contextualize the prospective findings and allow comparison between patients evaluated in the era of smCPET-enabled preoperative assessment and an earlier period without routine smCPET integration. Together, the two components create a hybrid repository structure: a prospective observational cohort of clinically evaluated patients supplemented by retrospective clinical data for validation and comparison.
This is an observational study. No experimental intervention is assigned by the investigators, no treatment is randomized, and no additional clinical procedures are mandated solely for research participation. All smCPET procedures included in the repository are performed as part of standard preoperative clinical care and surgical planning. Research participation pertains to collection, storage, linkage, de-identification, and analysis of clinical and outcome data. Accordingly, the study is intended to characterize associations and predictive relationships rather than test efficacy of an intervention.
The target population consists of adults older than 45 years who are presenting for moderate- to high-risk noncardiac surgery and who undergo evaluation in the Yale Pre-Surgical Evaluation Clinic. Patients are identified through routine clinic screening workflows, including triage processes, clinic screening tools, and clinician referral pathways based on clinical concern for elevated perioperative risk or impaired functional capacity. The protocol describes referral and screening criteria that include low estimated activity capacity and selected high-risk cardiovascular features within the broader context of moderate- to high-risk surgery. Participants are recruited from the future pool of preoperative smCPET patients at the Yale Pre-Surgical Evaluation Clinic. Because the study draws from a real-world clinical population evaluated in routine care, the repository is intended to reflect pragmatic perioperative practice rather than an artificially selected experimental cohort.
Screening for clinical smCPET occurs through the standard Yale Pre-Surgical Evaluation Clinic process. Primary screening may be conducted by triage nursing using the clinic screening tool or by referral using predefined criteria related to surgical risk, functional capacity assessment, or high-risk clinical features. Enrollment into the repository occurs after the smCPET and preoperative evaluation appointment. Potential participants are first introduced to the study by the clinical care team during the routine clinic visit, after which a study team member provides a brief explanation of the repository and consent process. This approach is intended to preserve separation between clinical care decisions and research participation. Enrollment discussions are conducted privately, bilingual interpretation is available when needed, and study personnel use a structured consent process that includes verification of understanding. Participants are informed that participation is voluntary and that a decision about repository enrollment will not affect clinical care.
The repository uses a dual-track consent approach. Prospective participants undergoing clinical smCPET are asked to provide written informed consent for inclusion in the repository and associated follow-up data collection. The consent process addresses storage of clinical and outcome data, future analysis within the repository framework, and the protections used for confidentiality and secure handling of identifiable information. For data elements that require access to the medical record for outcome ascertainment, identifiers may be temporarily retained under the authority of the principal investigator until outcome linkage is complete. Once the required linkage and validation steps are finished, identifiers are removed and replaced with a unique study code. De-identified data are stored in a secure encrypted REDCap database or other institutionally approved system. Access to identified information is limited to authorized study personnel, and any external sharing of de-identified data requires principal investigator and institutional review oversight as applicable.
Data collected in the repository are broad and designed to support both primary and secondary analyses. The core exposure domain includes physiologic variables derived from submaximal cardiopulmonary exercise testing performed in routine clinical care. These may include peak oxygen uptake achieved during the submaximal test, anaerobic threshold, ventilatory efficiency metrics, oxygen uptake efficiency and slope-based exercise measures, heart rate and blood pressure response, oxygen saturation trends, and related respiratory or metabolic parameters available from the clinical test platform. The specific smCPET variables available for analysis may evolve as the clinical program matures, but the repository is designed to preserve standardized capture of variables judged clinically and scientifically relevant for perioperative risk stratification.
In addition to smCPET variables, the repository captures demographic data and baseline clinical characteristics relevant to perioperative risk. These include age, sex, body mass index, comorbidity burden, and selected information from preoperative evaluation such as serum chemistries, hematologic data, echocardiography findings, radiographic data, and other clinically obtained investigations. The perioperative data structure also includes physiological variables such as heart rate, blood pressure, oxygen saturation, and pulse-related measures, along with procedure-related descriptors and other perioperative characteristics available in the medical record. Because the repository is built around routine clinical care, the exact distribution of covariates will reflect real-world practice patterns and clinical documentation.
Outcome ascertainment is a major purpose of the repository. The study is designed to examine both early postoperative morbidity and later complications after surgery. Early postoperative complications include events recorded using the Postoperative Morbidity Survey framework and related complication domains during the immediate postoperative period. These domains include pulmonary, infectious, renal, gastrointestinal, cardiovascular, neurological, hematological, wound, and pain-related complications, assessed at designated postoperative time points such as days 1, 3, and 5 when available. The repository also captures later postoperative events, including 30-day and 60-day complications and mortality outcomes. Examples of later complications listed in the protocol include myocardial infarction, angina, stroke, atrial fibrillation, surgical site infection, postoperative pneumonia, and other organ-specific complications identified through readmission records, postoperative follow-up, or clinical documentation. Length of stay and resource utilization measures are also included to support broader health services analyses.
The primary objective of the repository is to evaluate the association between established clinical smCPET measures and postoperative outcomes in patients who undergo preoperative smCPET as part of standard care. A key aim is to determine whether smCPET-derived variables can identify thresholds or patterns associated with increased risk of early postoperative complications and clinically important later adverse events. The repository is also intended to support development and refinement of predictive models using clinically available exercise-derived physiologic data. By identifying thresholds or multivariable patterns associated with increased risk, the study aims to provide evidence supporting the use of smCPET as an objective adjunct to existing perioperative evaluation strategies.
Secondary aims include validation of preliminary observations from earlier implementation work, subgroup analyses in clinically relevant patient subsets, comparison of smCPET-era patients with historical controls, and exploratory evaluation of cost-effectiveness, quality metrics, and resource utilization. The retrospective validation component enables comparison between contemporary patients assessed with smCPET-integrated workflows and historical cohorts from the period before smCPET implementation. This may help clarify whether the addition of structured physiologic assessment is associated with differences in triage, outcome profiles, or resource use, although causal interpretation will remain limited by the observational design. The repository may also support future studies evaluating whether smCPET variables can assist in identifying candidates for perioperative optimization, enhanced surveillance, or targeted prehabilitation strategies.
The planned analytic framework includes threshold determination for candidate smCPET measures, prediction modeling for postoperative outcomes, and comparative analyses involving the historical control cohort. Statistical work will focus on the strength and consistency of associations between smCPET variables and outcomes after accounting for relevant clinical covariates. The study is expected to use descriptive statistics to characterize the cohort, univariable and multivariable methods to evaluate associations, and model performance approaches appropriate for risk prediction analyses. Depending on the available sample and event rates, analyses may examine discrimination, calibration, and incremental prognostic value beyond routinely available clinical variables. Subgroup analyses may explore heterogeneity according to surgical risk, comorbidity burden, or other clinically meaningful strata. Because the study is repository-based and observational, all analyses will be interpreted in light of potential confounding, selection effects, and missing data.
The repository is expected to enroll approximately 1,500 participants. This sample size is intended to support evaluation of associations across a range of minor and major perioperative outcomes, though the effective sample for specific analyses will depend on event frequencies, completeness of testing, and availability of follow-up. The study is conducted at a single center, which supports consistency in testing workflow and outcome capture but may limit generalizability to other institutions with different patient populations or perioperative practices. Nonetheless, the pragmatic real-world setting is an important strength because it allows evaluation of smCPET within the actual environment in which it may ultimately be used.
The design has several anticipated strengths. First, smCPET data are derived from routine clinical care rather than an artificial research-only protocol, enhancing practical relevance. Second, the repository links physiologic testing to detailed perioperative outcomes, allowing evaluation across early morbidity, later complications, length of stay, and mortality. Third, the prospective data collection structure combined with retrospective validation data provides a richer framework than either approach alone. Fourth, the single-site workflow may improve internal consistency in screening, test conduct, data handling, and follow-up. Finally, the repository may generate reusable infrastructure and de-identified datasets that support future methodologic and translational perioperative research.
The study also has expected limitations. Because there is no randomization and no investigator-assigned intervention, analyses can identify associations but cannot by themselves establish that smCPET-guided care improves outcomes. Patients referred for clinical smCPET are a selected subgroup of the broader surgical population and may differ systematically from patients not tested. Historical comparisons may be influenced by secular changes in practice, case mix, perioperative management, and documentation quality. As with any clinical repository, missing data and variability in routine-care measurement may affect some analyses. The investigators therefore intend to treat this repository as a platform for careful prognostic evaluation and hypothesis generation, not as definitive proof of causal benefit.
Data security and confidentiality are central operational features of the repository. Identifiable clinical information needed for linkage and follow-up is handled under the supervision of the principal investigator and authorized study staff. Electronic data are maintained in encrypted REDCap or comparable secure systems, and paper materials, when applicable, are stored in locked locations with restricted access. Once linkage is complete, data are coded and de-identified for long-term storage and analysis. The protocol states that digital storage may be indefinite, subject to institutional oversight. External use of repository data requires appropriate approval, and any shared data will be de-identified, limited to the minimum necessary variables, and governed by data use expectations designed to prevent unauthorized redistribution or attempts at re-identification.
Monitoring and data quality procedures are included to support integrity of the repository. The protocol describes systematic data quality assurance processes, screening and eligibility documentation, controlled access to records, internal monitoring by the repository director or principal investigator, and periodic oversight of data requests and protocol modifications. These procedures are intended to align with Good Clinical Practice principles applicable to a repository study, even though the project is noninterventional. The repository structure also allows documentation of withdrawals, administrative removals, incomplete testing, and other circumstances that may affect analytic eligibility.
Participants may be removed from the repository for voluntary withdrawal, administrative reasons, or clinical circumstances. Voluntary withdrawal can occur at any time without penalty and without impact on clinical care. Administrative removal may occur if ongoing consent cannot be maintained or other repository conditions are no longer met. Clinical removal may occur in cases such as inability to complete smCPET, inadequate test quality, or change in surgical status. The study team documents removal status and determines the extent to which already collected data may be retained or withdrawn in accordance with consent, institutional policy, and regulatory requirements.
The broader long-term significance of SAMPO is to establish whether a brief, scalable physiologic assessment performed during routine preoperative care can contribute meaningful prognostic information for adults facing moderate- to high-risk noncardiac surgery. If smCPET measures demonstrate reproducible associations with early postoperative morbidity, major complications, and later outcomes, the findings may support wider perioperative adoption of brief objective exercise testing, more efficient identification of higher-risk patients, and better targeting of perioperative resources. The repository is also intended to create a foundation for future external validation studies, clinical prediction tool development, implementation evaluations, and eventually interventional trials testing whether smCPET-informed care pathways can improve outcomes.
In summary, SAMPO is a single-center observational repository study that captures routine-care preoperative submaximal cardiopulmonary exercise testing data and links those data to detailed perioperative and postoperative outcomes in adults undergoing moderate- to high-risk noncardiac surgery. The study combines prospective enrollment of clinically evaluated patients with retrospective historical comparison data, uses secure repository methods for data storage and de-identification, and focuses on validating feasible physiologic markers of perioperative risk. Through this work, the investigators seek to improve objective preoperative risk assessment and build a practical evidence base for integrating brief cardiopulmonary exercise measures into surgical evaluation pathways.
- Being tested
- Recruited participants receive preoperative rapid submaximal cardiopulmonary exercise testing within the current risk assessment framework of the pre-surgical evaluation clinic
- Keywords
- preoperative evaluation, submaximal cardiopulmonary exercise testing, major adverse cardiovascular events, preoperative risk stratification, high risk evaluation
- Medical subject headings
- Postoperative Complications
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Recruited participants receive preoperative rapid submaximal cardiopulmonary exercise testing within the current risk assessment framework of the pre-surgical evaluation clinicDiagnostic test
Also called submaximal cardiopulmonary exercise testing
A six minute submaximal cardiopulmonary exercise test that is used to identify cardiopulmonary abnormalities associated with heart and lung disease. This seeks to aid the physician in prescribing preoperative interventions to reduce postoperative cardiopulmonary complications.
| Study group | Role | What they receive |
|---|---|---|
| Submaximal CPET guided high-risk preoperative evaluation | Patients from high-risk evaluation preoperative referrals Receives: Diagnostic Test: Recruited participants receive preoperative rapid submaximal cardiopulmonary exercise testing within the current risk assessment framework of the pre-surgical evaluation clinic |
What is being measured
The primary outcome is the main question the study is designed to answer.
Major adverse cardiovascular events
Composite Cardiovascular death, acute heart failure, cardiac arrythymias, perioperative myocardia infarction/injury in the 30 days after surgical procedure.
Measured: 30 days
Secondary outcomes (7)
Early Postoperative Complications
Postoperative Morbidity Survey (POMS) where 0 is no complication and >1 is positive for early postoperative complication.
Measured: 5 days
Early Neurological Outcomes (Confusion Assessment Method (CMA) for the ICU-7 Delirium Severity Scale (CAM-ICU))
Assessment of nurse-recorded delirium assessments (CAM-ICU)
Measured: Up to 5 days after surgical procedure; 0-5 scale (0=absent, 5=severe delirium)
Early Renal Outcomes
Postoperative acute kidney injury KDIGO (Kidney Disease Improving Global Outcomes criteria) postoperative day 1, 3, 5.
- Serum creatinine levels on postoperative day 1, 3, 5
Measured: Postoperative Day 0-5
Surgical Site Infection
Physician documentation of surgical site infection
Measured: 30 days
Postoperative functional recovery (patient-centered outcome)
Postoperative quality of recovery at 30 days (discharge disposition). NIH associated data standards: Routine (Home/Self-care), Skilled Nursing Facility (SNF), Intermediate Care Facility (ICF), Home Health Care (HHC), Another Hospital/Facility, Against Medical Advice (AMA), Died. Optimal outcome: Routine; Least desirable: Died.
Measured: 30 days
Readmission
Readmission (any cause) after surgical procedure
Measured: 30 days
Healthcare Utilization Indicator: ICU admission duration
Duration of intensive care unit stay (in hours)
Measured: 30 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Apr 2026
- Study start23 Jul 2025
- Primary completion30 Jan 2028 (estimated)
- Study completion30 Jul 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for Postoperative Complications (Cardiopulmonary)Studies of the same condition, open and under way.
- More trials run by Yale UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 992 participants (estimated)
- Target duration
- 1 Year
Sponsor and investigators
- Lead sponsor
- Yale University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Zyad Carr, Yale University
- Investigators
- Zyad J Carr, M.D., Principal investigator, Yale University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07519733
- Sponsor's protocol ID
- 2000039292
- Acronym
- SAMPO
- Status last verified
- Apr 2026
- First submitted
- 27 Mar 2026
- Last updated
- 9 Apr 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: De-identified individual participant data underlying the results reported from this repository study will be shared with qualified researchers upon reasonable request. Shared data may include participant-level demographic characteristics, baseline clinical and comorbidity data, preoperative assessment variables, routine laboratory and imaging findings, submaximal cardiopulmonary exercise testing measures, perioperative physiological variables, and postoperative outcomes relevant to the approved analysis. Supporting materials, including the protocol, data dictionary, variable definitions, and analytic code when available, may also be shared. Access will be limited to investigators with a scientifically sound proposal and, where applicable, appropriate ethics approval. Data will be released only after review and approval by the Principal Investigator and completion of a data use agreement. All data will be de-identified, and direct identifiers or high-risk variables will not be shared.
Publications
Carr ZJ, Agarkov D, Li J, Charchaflieh J, Brenes-Bastos A, Freund J, Zafar J, Schonberger RB, Heerdt P. Implementation of Brief Submaximal Cardiopulmonary Testing in a High-Volume Presurgical Evaluation Clinic: Feasibility Cohort Study. JMIR Perioper Med. 2025 Feb 17;8:e65805. doi: 10.2196/65805.
PubMed 39773953Carr ZJ, Charchaflieh J, Brenes-Bastos A, He H, Lin HM, Jankelovits A, Gu E, Zafar J, Ghali F, Tan WS, Heerdt P. Preoperative submaximal cardiopulmonary exercise testing and its association with early postoperative complications. BJA Open. 2025 Apr 24;14:100407. doi: 10.1016/j.bjao.2025.100407. eCollection 2025 Jun.
PubMed 40421445Snowden CP, Prentis JM, Anderson HL, Roberts DR, Randles D, Renton M, Manas DM. Submaximal cardiopulmonary exercise testing predicts complications and hospital length of stay in patients undergoing major elective surgery. Ann Surg. 2010 Mar;251(3):535-41. doi: 10.1097/SLA.0b013e3181cf811d.
PubMed 20134313Older P, Hall A, Hader R. Cardiopulmonary exercise testing as a screening test for perioperative management of major surgery in the elderly. Chest. 1999 Aug;116(2):355-62. doi: 10.1378/chest.116.2.355.
PubMed 10453862Wijeysundera DN, Pearse RM, Shulman MA, Abbott TEF, Torres E, Ambosta A, Croal BL, Granton JT, Thorpe KE, Grocott MPW, Farrington C, Myles PS, Cuthbertson BH; METS study investigators. Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study. Lancet. 2018 Jun 30;391(10140):2631-2640. doi: 10.1016/S0140-6736(18)31131-0.
PubMed 30070222Beckerleg W, Kobewka D, Wijeysundera DN, Sood MM, McIsaac DI. Association of Preoperative Medical Consultation With Reduction in Adverse Postoperative Outcomes and Use of Processes of Care Among Residents of Ontario, Canada. JAMA Intern Med. 2023 May 1;183(5):470-478. doi: 10.1001/jamainternmed.2023.0325.
PubMed 36972037
Study at a glance
From the registry record, last updated by the sponsor on 9 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Submaximal Cardiopulmonary Exercise Testing in Adults Presenting for Moderate to High-risk Surgery and Perioperative Outcomes
- ClinicalTrials.gov ID
- NCT07519733
- Acronym / sponsor ID
- SAMPO / 2000039292
- Keywords
- preoperative evaluation, submaximal cardiopulmonary exercise testing, major adverse cardiovascular events, preoperative risk stratification, high risk evaluation
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 992 participants (estimated)
- Lead sponsor
- Yale UniversityUniversity, hospital or other
- Study start
- 23 Jul 2025 (actual)
- Primary completion
- 30 Jan 2028 (estimated)
- Study completion
- 30 Jul 2028 (estimated)
- First posted
- 9 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to learn whether results from a brief exercise test done before surgery can help identify adults who may be more likely to have problems after moderate- to high-risk noncardiac surgery. The study includes adults older than 45 years who are seen in a pre-surgical evaluation clinic and complete submaximal cardiopulmonary exercise testing, or smCPET, as part of their usual clinical care. The main questions it aims to answer are:
Are smCPET measurements linked with early problems after surgery? Are smCPET measurements linked with later problems after surgery, including complications within 30 and 60 days, longer hospital stay, and death? Can smCPET add useful information to standard preoperative risk assessment? Researchers will observe and analyze information collected during routine care. No extra exercise testing or treatment will be done for research.
Participants will:
- Complete routine preoperative evaluation in the Yale Pre-Surgical Evaluation Clinic.
- Undergo smCPET if it is ordered as part of standard clinical care.
- Allow researchers to collect information from the medical record and from the exercise test for the study repository, if they agree to participate.
The study will collect de-identified information about each participant's health before surgery, exercise test results, details about the surgery and hospital stay, and problems that happen after surgery. This may include age, sex, body mass index, other medical conditions, routine lab and imaging results, heart rate, blood pressure, oxygen levels, smCPET measures such as peak oxygen uptake, anaerobic threshold, and breathing efficiency, and early and late postoperative outcomes.
Researchers will look at short-term and later outcomes after surgery. These include problems identified during the hospital stay, such as heart, lung, kidney, nerve, blood, wound, and pain-related complications, as well as complications within 30 and 60 days after surgery. Researchers will also study hospital length of stay and death after surgery.
This study is designed to help researchers understand whether a short, practical exercise test can improve the way surgical risk is assessed before an operation. Current preoperative assessment tools do not always measure how well the heart, lungs, and muscles work together during physical stress. smCPET may provide a more objective way to measure functional capacity and physiologic reserve in a busy clinic setting.
This is a single-center study based in a preoperative evaluation clinic. The study has a prospective observational cohort component and a retrospective validation component. In the prospective part, adults who meet clinic criteria and complete smCPET during routine care may be asked to join the repository. In the retrospective part, researchers may also review historical data from patients evaluated before smCPET was put into routine use to help compare outcomes and validate findings.
Because this is an observational repository study, participation does not change the care participants receive. The exercise test is done for clinical reasons, not because of the research study. The research team will not assign treatments or decide what surgery a participant has. Instead, the team will study how exercise test findings relate to outcomes that occur after surgery.
The long-term aim of this study is to improve preoperative risk assessment and help clinicians better identify patients who may need closer monitoring, more evaluation, or more support around the time of surgery. If the findings are useful, they may support broader use of brief preoperative exercise testing in adults having higher-risk noncardiac surgery.
Detailed description
Submaximal Cardiopulmonary Exercise Testing in Adults Presenting for Moderate- to High-risk Surgery and Perioperative Outcomes (SAMPO) is a single-center prospective observational cohort repository with a retrospective validation component designed to evaluate whether measures derived from brief, clinically integrated submaximal cardiopulmonary exercise testing (smCPET) are associated with perioperative outcomes in adults undergoing moderate- to high-risk noncardiac surgery. The repository is being developed in the Yale New Haven Hospital Pre-Surgical Evaluation Clinic to support systematic collection, curation, and analysis of exercise-derived physiologic data obtained during routine preoperative care, together with clinical, perioperative, and postoperative outcome data. The overall purpose is to determine whether smCPET variables can improve perioperative risk stratification, identify patients at increased risk for postoperative complications, and generate a scalable framework for future perioperative risk modeling and implementation studies.
Perioperative complications remain common after major noncardiac surgery and are associated with increased morbidity, prolonged recovery, higher readmission rates, greater resource use, and higher health care costs. Current preoperative risk assessment often relies on history, comorbidity burden, procedural risk classification, and subjective estimates of functional capacity. Although formal cardiopulmonary exercise testing has demonstrated value for perioperative prognostication, broad adoption has been limited by the time, personnel, technical, and infrastructure requirements of conventional maximal testing. A brief submaximal approach may offer a more pragmatic alternative in the preoperative clinic setting. Early implementation work by the investigators suggests that rapid smCPET can be integrated into routine workflow, produces technically usable data in a high proportion of patients, and may yield physiologic measures associated with early postoperative morbidity. This repository is intended to extend that work by creating a structured dataset that allows more rigorous assessment of the relationship between preoperative smCPET findings and clinically meaningful postoperative outcomes.
The central scientific premise of the repository is that preoperative physiologic response to submaximal exercise reflects cardiopulmonary reserve and integrative functional capacity in ways not fully captured by routine clinical history or conventional screening instruments. Variables such as peak oxygen uptake achieved during submaximal effort, anaerobic threshold, ventilatory efficiency, heart rate response, and slope-based exercise measures may identify latent vulnerability before surgery. If those measures show meaningful associations with early and later postoperative complications, they may support more objective risk assessment, perioperative triage, allocation of optimization resources, and selection of patients for enhanced monitoring or future interventional studies. The repository is therefore designed not merely as a passive data storage effort, but as an analytic infrastructure for validating clinically feasible physiologic markers in the perioperative setting.
The study includes a prospective component and a retrospective component. In the prospective component, adult participants undergoing routine preoperative evaluation in the Yale Pre-Surgical Evaluation Clinic who are referred for or complete smCPET as part of clinical care are approached for consent for inclusion in the repository. smCPET is not performed for research purposes; rather, the study captures data already generated during standard clinical assessment and links those data to perioperative and postoperative outcomes. The planned initial enrollment period is 36 months with follow-up extending through the perioperative period and including later outcome ascertainment. The protocol also describes an overall study duration of 48 months and a single study site.
The retrospective component consists of historical data from the period before clinical implementation of smCPET, including approximately 24 months of historical control data to support validation, comparison, matched cohort analyses, and evaluation of outcomes, costs, and resource utilization patterns. This aspect of the study is intended to contextualize the prospective findings and allow comparison between patients evaluated in the era of smCPET-enabled preoperative assessment and an earlier period without routine smCPET integration. Together, the two components create a hybrid repository structure: a prospective observational cohort of clinically evaluated patients supplemented by retrospective clinical data for validation and comparison.
This is an observational study. No experimental intervention is assigned by the investigators, no treatment is randomized, and no additional clinical procedures are mandated solely for research participation. All smCPET procedures included in the repository are performed as part of standard preoperative clinical care and surgical planning. Research participation pertains to collection, storage, linkage, de-identification, and analysis of clinical and outcome data. Accordingly, the study is intended to characterize associations and predictive relationships rather than test efficacy of an intervention.
The target population consists of adults older than 45 years who are presenting for moderate- to high-risk noncardiac surgery and who undergo evaluation in the Yale Pre-Surgical Evaluation Clinic. Patients are identified through routine clinic screening workflows, including triage processes, clinic screening tools, and clinician referral pathways based on clinical concern for elevated perioperative risk or impaired functional capacity. The protocol describes referral and screening criteria that include low estimated activity capacity and selected high-risk cardiovascular features within the broader context of moderate- to high-risk surgery. Participants are recruited from the future pool of preoperative smCPET patients at the Yale Pre-Surgical Evaluation Clinic. Because the study draws from a real-world clinical population evaluated in routine care, the repository is intended to reflect pragmatic perioperative practice rather than an artificially selected experimental cohort.
Screening for clinical smCPET occurs through the standard Yale Pre-Surgical Evaluation Clinic process. Primary screening may be conducted by triage nursing using the clinic screening tool or by referral using predefined criteria related to surgical risk, functional capacity assessment, or high-risk clinical features. Enrollment into the repository occurs after the smCPET and preoperative evaluation appointment. Potential participants are first introduced to the study by the clinical care team during the routine clinic visit, after which a study team member provides a brief explanation of the repository and consent process. This approach is intended to preserve separation between clinical care decisions and research participation. Enrollment discussions are conducted privately, bilingual interpretation is available when needed, and study personnel use a structured consent process that includes verification of understanding. Participants are informed that participation is voluntary and that a decision about repository enrollment will not affect clinical care.
The repository uses a dual-track consent approach. Prospective participants undergoing clinical smCPET are asked to provide written informed consent for inclusion in the repository and associated follow-up data collection. The consent process addresses storage of clinical and outcome data, future analysis within the repository framework, and the protections used for confidentiality and secure handling of identifiable information. For data elements that require access to the medical record for outcome ascertainment, identifiers may be temporarily retained under the authority of the principal investigator until outcome linkage is complete. Once the required linkage and validation steps are finished, identifiers are removed and replaced with a unique study code. De-identified data are stored in a secure encrypted REDCap database or other institutionally approved system. Access to identified information is limited to authorized study personnel, and any external sharing of de-identified data requires principal investigator and institutional review oversight as applicable.
Data collected in the repository are broad and designed to support both primary and secondary analyses. The core exposure domain includes physiologic variables derived from submaximal cardiopulmonary exercise testing performed in routine clinical care. These may include peak oxygen uptake achieved during the submaximal test, anaerobic threshold, ventilatory efficiency metrics, oxygen uptake efficiency and slope-based exercise measures, heart rate and blood pressure response, oxygen saturation trends, and related respiratory or metabolic parameters available from the clinical test platform. The specific smCPET variables available for analysis may evolve as the clinical program matures, but the repository is designed to preserve standardized capture of variables judged clinically and scientifically relevant for perioperative risk stratification.
In addition to smCPET variables, the repository captures demographic data and baseline clinical characteristics relevant to perioperative risk. These include age, sex, body mass index, comorbidity burden, and selected information from preoperative evaluation such as serum chemistries, hematologic data, echocardiography findings, radiographic data, and other clinically obtained investigations. The perioperative data structure also includes physiological variables such as heart rate, blood pressure, oxygen saturation, and pulse-related measures, along with procedure-related descriptors and other perioperative characteristics available in the medical record. Because the repository is built around routine clinical care, the exact distribution of covariates will reflect real-world practice patterns and clinical documentation.
Outcome ascertainment is a major purpose of the repository. The study is designed to examine both early postoperative morbidity and later complications after surgery. Early postoperative complications include events recorded using the Postoperative Morbidity Survey framework and related complication domains during the immediate postoperative period. These domains include pulmonary, infectious, renal, gastrointestinal, cardiovascular, neurological, hematological, wound, and pain-related complications, assessed at designated postoperative time points such as days 1, 3, and 5 when available. The repository also captures later postoperative events, including 30-day and 60-day complications and mortality outcomes. Examples of later complications listed in the protocol include myocardial infarction, angina, stroke, atrial fibrillation, surgical site infection, postoperative pneumonia, and other organ-specific complications identified through readmission records, postoperative follow-up, or clinical documentation. Length of stay and resource utilization measures are also included to support broader health services analyses.
The primary objective of the repository is to evaluate the association between established clinical smCPET measures and postoperative outcomes in patients who undergo preoperative smCPET as part of standard care. A key aim is to determine whether smCPET-derived variables can identify thresholds or patterns associated with increased risk of early postoperative complications and clinically important later adverse events. The repository is also intended to support development and refinement of predictive models using clinically available exercise-derived physiologic data. By identifying thresholds or multivariable patterns associated with increased risk, the study aims to provide evidence supporting the use of smCPET as an objective adjunct to existing perioperative evaluation strategies.
Secondary aims include validation of preliminary observations from earlier implementation work, subgroup analyses in clinically relevant patient subsets, comparison of smCPET-era patients with historical controls, and exploratory evaluation of cost-effectiveness, quality metrics, and resource utilization. The retrospective validation component enables comparison between contemporary patients assessed with smCPET-integrated workflows and historical cohorts from the period before smCPET implementation. This may help clarify whether the addition of structured physiologic assessment is associated with differences in triage, outcome profiles, or resource use, although causal interpretation will remain limited by the observational design. The repository may also support future studies evaluating whether smCPET variables can assist in identifying candidates for perioperative optimization, enhanced surveillance, or targeted prehabilitation strategies.
The planned analytic framework includes threshold determination for candidate smCPET measures, prediction modeling for postoperative outcomes, and comparative analyses involving the historical control cohort. Statistical work will focus on the strength and consistency of associations between smCPET variables and outcomes after accounting for relevant clinical covariates. The study is expected to use descriptive statistics to characterize the cohort, univariable and multivariable methods to evaluate associations, and model performance approaches appropriate for risk prediction analyses. Depending on the available sample and event rates, analyses may examine discrimination, calibration, and incremental prognostic value beyond routinely available clinical variables. Subgroup analyses may explore heterogeneity according to surgical risk, comorbidity burden, or other clinically meaningful strata. Because the study is repository-based and observational, all analyses will be interpreted in light of potential confounding, selection effects, and missing data.
The repository is expected to enroll approximately 1,500 participants. This sample size is intended to support evaluation of associations across a range of minor and major perioperative outcomes, though the effective sample for specific analyses will depend on event frequencies, completeness of testing, and availability of follow-up. The study is conducted at a single center, which supports consistency in testing workflow and outcome capture but may limit generalizability to other institutions with different patient populations or perioperative practices. Nonetheless, the pragmatic real-world setting is an important strength because it allows evaluation of smCPET within the actual environment in which it may ultimately be used.
The design has several anticipated strengths. First, smCPET data are derived from routine clinical care rather than an artificial research-only protocol, enhancing practical relevance. Second, the repository links physiologic testing to detailed perioperative outcomes, allowing evaluation across early morbidity, later complications, length of stay, and mortality. Third, the prospective data collection structure combined with retrospective validation data provides a richer framework than either approach alone. Fourth, the single-site workflow may improve internal consistency in screening, test conduct, data handling, and follow-up. Finally, the repository may generate reusable infrastructure and de-identified datasets that support future methodologic and translational perioperative research.
The study also has expected limitations. Because there is no randomization and no investigator-assigned intervention, analyses can identify associations but cannot by themselves establish that smCPET-guided care improves outcomes. Patients referred for clinical smCPET are a selected subgroup of the broader surgical population and may differ systematically from patients not tested. Historical comparisons may be influenced by secular changes in practice, case mix, perioperative management, and documentation quality. As with any clinical repository, missing data and variability in routine-care measurement may affect some analyses. The investigators therefore intend to treat this repository as a platform for careful prognostic evaluation and hypothesis generation, not as definitive proof of causal benefit.
Data security and confidentiality are central operational features of the repository. Identifiable clinical information needed for linkage and follow-up is handled under the supervision of the principal investigator and authorized study staff. Electronic data are maintained in encrypted REDCap or comparable secure systems, and paper materials, when applicable, are stored in locked locations with restricted access. Once linkage is complete, data are coded and de-identified for long-term storage and analysis. The protocol states that digital storage may be indefinite, subject to institutional oversight. External use of repository data requires appropriate approval, and any shared data will be de-identified, limited to the minimum necessary variables, and governed by data use expectations designed to prevent unauthorized redistribution or attempts at re-identification.
Monitoring and data quality procedures are included to support integrity of the repository. The protocol describes systematic data quality assurance processes, screening and eligibility documentation, controlled access to records, internal monitoring by the repository director or principal investigator, and periodic oversight of data requests and protocol modifications. These procedures are intended to align with Good Clinical Practice principles applicable to a repository study, even though the project is noninterventional. The repository structure also allows documentation of withdrawals, administrative removals, incomplete testing, and other circumstances that may affect analytic eligibility.
Participants may be removed from the repository for voluntary withdrawal, administrative reasons, or clinical circumstances. Voluntary withdrawal can occur at any time without penalty and without impact on clinical care. Administrative removal may occur if ongoing consent cannot be maintained or other repository conditions are no longer met. Clinical removal may occur in cases such as inability to complete smCPET, inadequate test quality, or change in surgical status. The study team documents removal status and determines the extent to which already collected data may be retained or withdrawn in accordance with consent, institutional policy, and regulatory requirements.
The broader long-term significance of SAMPO is to establish whether a brief, scalable physiologic assessment performed during routine preoperative care can contribute meaningful prognostic information for adults facing moderate- to high-risk noncardiac surgery. If smCPET measures demonstrate reproducible associations with early postoperative morbidity, major complications, and later outcomes, the findings may support wider perioperative adoption of brief objective exercise testing, more efficient identification of higher-risk patients, and better targeting of perioperative resources. The repository is also intended to create a foundation for future external validation studies, clinical prediction tool development, implementation evaluations, and eventually interventional trials testing whether smCPET-informed care pathways can improve outcomes.
In summary, SAMPO is a single-center observational repository study that captures routine-care preoperative submaximal cardiopulmonary exercise testing data and links those data to detailed perioperative and postoperative outcomes in adults undergoing moderate- to high-risk noncardiac surgery. The study combines prospective enrollment of clinically evaluated patients with retrospective historical comparison data, uses secure repository methods for data storage and de-identification, and focuses on validating feasible physiologic markers of perioperative risk. Through this work, the investigators seek to improve objective preoperative risk assessment and build a practical evidence base for integrating brief cardiopulmonary exercise measures into surgical evaluation pathways.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Year
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Submaximal CPET guided high-risk preoperative evaluation | – | Diagnostic Test: Recruited participants receive preoperative rapid submaximal cardiopulmonary exercise testing within the current risk assessment framework of the pre-surgical evaluation clinicPatients from high-risk evaluation preoperative referrals |
Who may qualify
- Ages
- 45 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- The pool of participants for enrollment in this data repository will be patients that have met criteria for preoperative smCPET screening with EITHER a * Modified Duke Activity Status Index9 score of <3 or Duke Activity Status Index < or = 34 * A surgeon's request for preoperative evaluation to assess fitness for surgery * An anesthesiologist request for preoperative evaluation to assess fitness for surgery. * A consulting physician request for preoperative evaluation to assess fitness for surgery. * Or a revised cardiac risk index10 of >2 with moderate to high risk features (coronary artery disease, cardiomyopathy, echocardiography with reduced ejection fraction, myocardial infarction w/in prior 12 months (but >6 weeks from scheduled surgery).
Key inclusion criteria (6 listed)
- greater than 45 years old
- moderate to high-risk noncardiac surgery
- surgeon, anesthesiologist or other medical provider requested referral for preoperative high risk evaluation, or
- revised cardiac risk index > or = 2, or
- Ambiguous, low or discordant functional capacity by either the Duke Activity status index (DASI <34) or the modified Duke Activity status index (< or =3) or
Key exclusion criteria (8 listed)
- Age <45
- Absolute contraindication to submaximal cardiopulmonary exercise testing
- Impaired decision making capacity
- Prisoners
- Pregnancy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Recruited participants receive preoperative rapid submaximal cardiopulmonary exercise testing within the current risk assessment framework of the pre-surgical evaluation clinicAlso: submaximal cardiopulmonary exercise testingA six minute submaximal cardiopulmonary exercise test that is used to identify cardiopulmonary abnormalities associated with heart and lung disease. This seeks to aid the physician in prescribing preoperative interventions to reduce postoperative cardiopulmonary complications. | Diagnostic test | Submaximal CPET guided high-risk preoperative evaluation |
Primary outcome
Major adverse cardiovascular events
Time frame: 30 days
Composite Cardiovascular death, acute heart failure, cardiac arrythymias, perioperative myocardia infarction/injury in the 30 days after surgical procedure.
7 secondary outcomes
Early Postoperative Complications
Time frame: 5 days
Early Neurological Outcomes (Confusion Assessment Method (CMA) for the ICU-7 Delirium Severity Scale (CAM-ICU))
Time frame: Up to 5 days after surgical procedure; 0-5 scale (0=absent, 5=severe delirium)
Early Renal Outcomes
Time frame: Postoperative Day 0-5
Surgical Site Infection
Time frame: 30 days
Postoperative functional recovery (patient-centered outcome)
Time frame: 30 days
Readmission
Time frame: 30 days
Healthcare Utilization Indicator: ICU admission duration
Time frame: 30 days
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Apr 2026.
- Background: PubMed 39773953Carr ZJ, Agarkov D, Li J, Charchaflieh J, Brenes-Bastos A, Freund J, Zafar J, Schonberger RB, Heerdt P. Implementation of Brief Submaximal Cardiopulmonary Testing in a High-Volume Presurgical Evaluation Clinic: Feasibility Cohort Study. JMIR Perioper Med. 2025 Feb 17;8:e65805. doi: 10.2196/65805.
- Background: PubMed 40421445Carr ZJ, Charchaflieh J, Brenes-Bastos A, He H, Lin HM, Jankelovits A, Gu E, Zafar J, Ghali F, Tan WS, Heerdt P. Preoperative submaximal cardiopulmonary exercise testing and its association with early postoperative complications. BJA Open. 2025 Apr 24;14:100407. doi: 10.1016/j.bjao.2025.100407. eCollection 2025 Jun.
- Background: PubMed 20134313Snowden CP, Prentis JM, Anderson HL, Roberts DR, Randles D, Renton M, Manas DM. Submaximal cardiopulmonary exercise testing predicts complications and hospital length of stay in patients undergoing major elective surgery. Ann Surg. 2010 Mar;251(3):535-41. doi: 10.1097/SLA.0b013e3181cf811d.
- Background: PubMed 10453862Older P, Hall A, Hader R. Cardiopulmonary exercise testing as a screening test for perioperative management of major surgery in the elderly. Chest. 1999 Aug;116(2):355-62. doi: 10.1378/chest.116.2.355.
- Background: PubMed 30070222Wijeysundera DN, Pearse RM, Shulman MA, Abbott TEF, Torres E, Ambosta A, Croal BL, Granton JT, Thorpe KE, Grocott MPW, Farrington C, Myles PS, Cuthbertson BH; METS study investigators. Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study. Lancet. 2018 Jun 30;391(10140):2631-2640. doi: 10.1016/S0140-6736(18)31131-0.
- Background: PubMed 36972037Beckerleg W, Kobewka D, Wijeysundera DN, Sood MM, McIsaac DI. Association of Preoperative Medical Consultation With Reduction in Adverse Postoperative Outcomes and Use of Processes of Care Among Residents of Ontario, Canada. JAMA Intern Med. 2023 May 1;183(5):470-478. doi: 10.1001/jamainternmed.2023.0325.
- Individual participant dataSharing planned: Yes. De-identified individual participant data underlying the results reported from this repository study will be shared with qualified researchers upon reasonable request. Shared data may include participant-level demographic characteristics, baseline clinical and comorbidity data, preoperative assessment variables, routine laboratory and imaging findings, submaximal cardiopulmonary exercise testing measures, perioperative physiological variables, and postoperative outcomes relevant to the approved analysis. Supporting materials, including the protocol, data dictionary, variable definitions, and analytic code when available, may also be shared. Access will be limited to investigators with a scientifically sound proposal and, where applicable, appropriate ethics approval. Data will be released only after review and approval by the Principal Investigator and completion of a data use agreement. All data will be de-identified, and direct identifiers or high-risk variables will not be shared.
Related trials for Postoperative Complications (Cardiopulmonary)
Recruiting
Mechanisms and Intervention Strategies of Perioperative Glycemic Variability on Postoperative Delirium
Cardiac Surgery With Cardiopulmonary Bypass, Postoperative Delirium
Active, not recruitingObservational study
SHAPE Test for Preoperative Risk Stratification
Perioperative/Postoperative Complications, Aerobic Capacity
Not yet recruiting
BrainProtect-guided, Real-time Cerebral Autoregulation Monitoring and Protection of Brain During Cardiac Surgery With Cardiopulmonary Bypass Requiring Heart-lung Machine
Cerebral Autoregulation Impairment, Postoperative Cognitive Dysfunction
Not yet recruiting
BIS in ICU Interventional Study
Cardiac Surgical Procedures (Postoperative Population), Critical Illness
Not yet recruitingObservational study
PCO₂ Gap and Lactate as Predictors of POCD After Cardiac Surgery
Postoperative Cognitive Dysfunction (POCD), Cardiac Surgery
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Zyad J Carr, M.D. principal investigator
Yale University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Postoperative Complications (Cardiopulmonary), run by Yale University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 9 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Zyad J Carr, M.D. (203.785.3689, zyad.carr@yale.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Major adverse cardiovascular events (time frame: 30 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07519733, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Apr 2026.